WAVE LIFE SCIENCES LTD. Payments to Acquire Short-term Investments
WAVE LIFE SCIENCES LTD. (WVE) reported Payments to Acquire Short-term Investments of $75.04 million for the 12-month period ending 2022-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2025-03-04
- WAVE LIFE SCIENCES LTD. payments to acquire short-term investments for the quarter ending 2022-12-31 was $0.00.
- WAVE LIFE SCIENCES LTD. payments to acquire short-term investments for the quarter ending 2022-09-30 was $25.04M.
- WAVE LIFE SCIENCES LTD. payments to acquire short-term investments for the quarter ending 2022-06-30 was $0.00.
- WAVE LIFE SCIENCES LTD. payments to acquire short-term investments for the quarter ending 2022-03-31 was $50.00M.
- WAVE LIFE SCIENCES LTD. payments to acquire short-term investments for fiscal 2022 was $75.04M.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $25.04M derived: sum of 2 quarters · filed 2025-03-04 | $25.04M derived: sum of 3 quarters · filed 2025-03-04 | $75.04M 10-K · filed 2025-03-04 |
| 2022-09-30 | $25.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $25.04M derived: sum of 2 quarters · filed 2023-11-09 | $75.04M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $50.00M 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | $50.00M 10-Q · filed 2023-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |